Kanion Pharmaceutical Adds 8 Drugs to National Essential Medicines List

Regulation
โดย 财中社·Read original
Summary · why it matters

Kanion Pharmaceutical announced that a total of 51 of its products have been included in the National Essential Medicines List, 2026 Edition, with 8 drugs newly added. In the first quarter of 2026, Kanion Pharmaceutical achieved revenue of 831 million yuan and net profit attributable to the parent company of 79.28 million yuan.

Impact on stocks 1

Others▲ · 1 stocks
© 2026 MarketDXNews